Forty-five FtM transsexuals were randomly assigned to receive testoviron depot ( i.m. : @mg/@ days ; n = @ ) , testosterone gel ( @mg/die ; n = @ ) , and testosterone undecanoate ( i.m. : @,@ mg every @ weeks for the first @ weeks and then every @ weeks , n = @ ) .